Login

Aram Mangasarian , CEO, NOXXON Pharma 00:00:00

Share On Facebook Share On Twitter

Aram Mangasarian présente Noxxon Pharma

Recent Videos

00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
00:10:00
James Anderson: Guanajuato Silver Expands with $50M Bolanitos Deal, Building Mexico’s Fastest-Growing Silver Producer|James Anderson,CHAIRMAN & CEO,Guanajuato Silver Company Ltd
00:10:00
Highland Copper Company Targets 2026 Construction Decision as Fully Permitted Copperwood Project Gains U.S. Federal Financing Momentum|Barry O’Shea,CEO,Highland Copper

Suggestions

00:10:00
Vance Howard on the HCM-BuyLine® and ETFs QQH and LGH on The Exchange by NYSE | Vance Howard - CEO and Portfolio Manager at Howard Capital Management.
00:10:00
Tim Brown on the Allbirds Journey: From Athletic Inspiration to Sustainable Footwear | Tim Brown, Co-Founder, Allbirds Inc.
00:10:00
Conservatism and Classical Music: Matthew Continetti's Insights|Alexander Boot,Professor,School of Transnational Governance
00:10:00
Alpha Financial Markets Consulting PLC's CEO Euan Fraser and Global Head of Asset and Wealth Management Luc Baqué discuss company insights and strategies.|Luc is Chief Executive Officer of Alpha
00:10:00
Community Leaders Panel: Aecon, Bird Construction, and IBI Group CEOs Discuss Building Blocks | Teri McKibbon President & Chief Executive Officer of bird construction inc
00:10:00
Coda Minerals' Development Progress and Future Plans
00:10:00
Tembo Gold Corporation's Presentation on Tanzanian Goldfield Exploration and Strategic Partnership with Barrick Gold
00:10:00
Wes Edens on Brightline's Growth and Future Prospects |Wes Edens, Co-Founder, Fortress Investment.
00:10:00
Blue Value Advisors: Your Guide from Business Assessment to Successful Exit
00:10:00
AAK AB Q2 2024 Interim Report: CEO Johan Westman’s Commentary | Johan Westman, CEO , AAK AB.
00:10:00
Disney's Success: Streaming Growth and Theme Park Revival
00:10:00
Founded in 1995. They are 26 years and 10 flagship funds strong, with over $6B assets|Steve Vassallo,General Partner,Foundation Capital

© 2017 - Neuhu+